March Biosciences Inc
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Long-term Follow-up Study of Patients Who Received MB-105 (NCT07340814) | March Biosciences Inc | 2026-02-27 |
| MB-105 in Patients With CD5 Positive T-cell Lymphoma (NCT06534060) | March Biosciences Inc | 2025-02-15 |
Track March Biosciences Inc automatically
Every clearance here is in the API, with alerts when new ones post.